Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark L Evans

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|June 26, 2018
Closed-Loop Insulin Delivery for Glycemic Control in Noncritical CareLia Bally, Hood Thabit, Sara Hartnell, et al.
Kidney International|May 29, 2019
Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysisLia Bally, Philipp Gubler, Hood Thabit, et al.
Endocrinology|July 23, 2014
5-HT obesity medication efficacy via POMC activation is maintained during agingLuke K Burke, Barbora Doslikova, Giuseppe D'Agostino, et al.
Diabetes Technology & Therapeutics|November 5, 2013
Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrationsLalantha Leelarathna, Shane W English, Hood Thabit, et al.
Critical Care (London, England)|July 26, 2013
Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trialLalantha Leelarathna, Shane W English, Hood Thabit, et al.
Diabetes, Obesity & Metabolism|April 6, 2021
Day-to-day variability of insulin requirements in the inpatient setting: Observations during fully closed-loop insulin deliveryCharlotte K Boughton, Aideen Daly, Hood Thabit, et al.
Journal of Diabetes Science and Technology|April 13, 2024
Hypoglycemia and Hyperglycemia According to Type of Diabetes: Observations During Fully Closed-Loop Insulin Delivery in Adults With Type 1 and Type 2 DiabetesNithya Kadiyala, Malgorzata E Wilinska, Aideen B Daly, et al.
The Lancet. Diabetes & Endocrinology|April 3, 2019
Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trialCharlotte K Boughton, Lia Bally, Franco Martignoni, et al.
The Lancet. Diabetes & Endocrinology|January 18, 2017
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover studyLia Bally, Hood Thabit, Harald Kojzar, et al.
Metabolism: Clinical and Experimental|July 30, 2010
Recurrent hypoglycemia increases hypothalamic glucose phosphorylation activity in ratsMayowa A Osundiji, Paul Hurst, Stephen P Moore, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|June 26, 2018
Closed-Loop Insulin Delivery for Glycemic Control in Noncritical CareLia Bally, Hood Thabit, Sara Hartnell, et al.
Kidney International|May 29, 2019
Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysisLia Bally, Philipp Gubler, Hood Thabit, et al.
Endocrinology|July 23, 2014
5-HT obesity medication efficacy via POMC activation is maintained during agingLuke K Burke, Barbora Doslikova, Giuseppe D'Agostino, et al.
Diabetes Technology & Therapeutics|November 5, 2013
Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrationsLalantha Leelarathna, Shane W English, Hood Thabit, et al.
Critical Care (London, England)|July 26, 2013
Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trialLalantha Leelarathna, Shane W English, Hood Thabit, et al.
Diabetes, Obesity & Metabolism|April 6, 2021
Day-to-day variability of insulin requirements in the inpatient setting: Observations during fully closed-loop insulin deliveryCharlotte K Boughton, Aideen Daly, Hood Thabit, et al.
Journal of Diabetes Science and Technology|April 13, 2024
Hypoglycemia and Hyperglycemia According to Type of Diabetes: Observations During Fully Closed-Loop Insulin Delivery in Adults With Type 1 and Type 2 DiabetesNithya Kadiyala, Malgorzata E Wilinska, Aideen B Daly, et al.
The Lancet. Diabetes & Endocrinology|April 3, 2019
Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trialCharlotte K Boughton, Lia Bally, Franco Martignoni, et al.
The Lancet. Diabetes & Endocrinology|January 18, 2017
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover studyLia Bally, Hood Thabit, Harald Kojzar, et al.
Metabolism: Clinical and Experimental|July 30, 2010
Recurrent hypoglycemia increases hypothalamic glucose phosphorylation activity in ratsMayowa A Osundiji, Paul Hurst, Stephen P Moore, et al.
Pageof 12